AI, Copyright, and Open Science: Health Implications of the New York Times/OpenAI Lawsuit
A rundown of the major legal questions at play in the New York Times-OpenAI lawsuit.
machine learning
-
Read more: AI, Copyright, and Open Science: Health Implications of the New York Times/OpenAI Lawsuit -
Read more: What’s on the Horizon for Health and Biotech with the AI Executive Order What’s on the Horizon for Health and Biotech with the AI Executive Order
Biden’s Executive Order on artificial intelligence is an important development for health care practitioners, researchers, and legal experts.
-
Read more: FDA Solicits Feedback on the Use of AI and Machine Learning in Drug Development FDA Solicits Feedback on the Use of AI and Machine Learning in Drug Development
The FDA has recently turned its attention to the growing use of artificial intelligence and machine learning in drug development.
-
Read more: A Closer Look at FDA’s Newly Released AI/ML Action Plan A Closer Look at FDA’s Newly Released AI/ML Action Plan
FDA’s new Action Plan takes steps toward establishing a dedicated regulatory strategy for AI products intended as software as a medical device.
-
Read more: Data Talking to Machines: The Intersection of Deep Phenotyping and Artificial Intelligence Data Talking to Machines: The Intersection of Deep Phenotyping and Artificial Intelligence
Researchers will need to consider when it is appropriate to leverage AI, versus when a human touch is needed.
-
Read more: Insufficient Protections for Health Data Privacy: Lessons from Dinerstein v. Google Insufficient Protections for Health Data Privacy: Lessons from Dinerstein v. Google
Dinerstein v. Google demonstrates gaps in HIPAA protections and the difficulty of pursuing claims against hospitals that share patient data with tech.
-
Read more: Understanding Racial Bias in Medical AI Training Data Understanding Racial Bias in Medical AI Training Data
By Adriana Krasniansky Interest in artificially intelligent (AI) health care has grown at an astounding pace: the global AI health care market is expected to reach $17.8 billion by 2025 and AI-powered systems are being designed to support medical activities ranging from patient diagnosis and triaging to drug pricing. Yet, as researchers across technology and…
-
Read more: Is Data Sharing Caring Enough About Patient Privacy? Part II: Potential Impact on US Data Sharing Regulations Is Data Sharing Caring Enough About Patient Privacy? Part II: Potential Impact on US Data Sharing Regulations
A recent US lawsuit highlights crucial challenges at the interface of data utility, patient privacy & data misuse By Timo Minssen (CeBIL, UCPH), Sara Gerke & Carmel Shachar Earlier, we discussed the new suit filed against Google, the University of Chicago (UC), and UChicago Medicine, focusing on the disclosure of patient data from UC to…
-
Read more: Is Data Sharing Caring Enough About Patient Privacy? Part I: The Background Is Data Sharing Caring Enough About Patient Privacy? Part I: The Background
By Timo Minssen (CeBIL, UCPH), Sara Gerke & Carmel Shachar A recent US lawsuit highlights crucial challenges at the interface of data utility, patient privacy & data misuse The huge prospects of artificial intelligence and machine learning (ML), as well as the increasing trend toward public-private partnerships in biomedical innovation, stress the importance of an effective…
-
Read more: Artificial Intelligence for Suicide Prediction Artificial Intelligence for Suicide Prediction
Suicide is a global problem that causes 800,000 deaths per year worldwide. In the United States, suicide rates rose by 25 percent in the past two decades, and suicide now kills 45,000 Americans each year, which is more than auto accidents or homicides. Traditional methods of predicting suicide, such as questionnaires administered by doctors, are…
